Search results
Results from the WOW.Com Content Network
Production of Norplant was discontinued globally in 2008. [21] Norplant II (Norplant-2, Jadelle), also developed by the Population Council and manufactured by Schering Oy, consists of two small (2.5 mm × 43 mm) silicone rods each containing 75 mg of levonorgestrel in a polymer matrix, instead of six capsules. It was approved May 31, 1996 by ...
[18] [19] Nexplanon was developed to eliminate the problem of non-insertion and localization of Implanon by changing the inserter device and making the rod radiopaque. [43] As of January 2012, Implanon is no longer being marketed and Nexplanon is the only available single-rod implant.
A contraceptive implant is an implantable medical device used for the purpose of birth control.The implant may depend on the timed release of hormones to hinder ovulation or sperm development, the ability of copper to act as a natural spermicide within the uterus, or it may work using a non-hormonal, physical blocking mechanism.
2002 [36] cervical cap and spermicide used by parous (discontinued in 2008) [37] [note 3] [note 5] Lea's Shield: 15 (1 in 6) no data: Barrier & spermicide: Vaginal insertion: Every act of intercourse: 1988 cervical cap and spermicide (discontinued in 2005) used by nulliparous [note 4] Prentif: 16 (1 in 6.25) 9 (1 in 11) Barrier & spermicide ...
Contraceptive use has been shown to reduce the rate of children born into poverty, [83] as parents are able to plan the correct financially stable time in which to have a child. In addition, unplanned pregnancies have been noted to cause splits of parents or child abandonment , which results in single-parent households that are more likely to ...
For the first time in over a decade, obesity rates in the United States may finally be heading in the right direction and new weight loss drugs like semaglutide could be part of the reason why. A ...
From or to a drug trade name: This is a redirect from (or to) the trade name of a drug to (or from) the international nonproprietary name (INN).
Breen’s suit claims Olson-Kennedy’s clinic put her on puberty blockers when she was just 12, started her on hormone therapy at 13 and performed a double mastectomy on her at 14.